TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive AACI Calls For New NCI Division For Centers. Other Programs, 75 Total Core Grants By 1992 May 6, 1988
TCL Archive Four cancer centers form privately-funded Multiple Myeloma Research Consortium. Plan grew out of a recommendation to NCI, but organizers didn’t want to wait for the government to take action. September 10, 2004
TCL Archive DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs December 4, 1992
